Amino acid signatures of HLA Class-I and II molecules are strongly associated with SLE susceptibility and autoantibody production in Eastern Asians

被引:37
|
作者
Molineros, Julio E. [1 ]
Looger, Loren L. [2 ]
Kim, Kwangwoo [3 ]
Okada, Yukinori [4 ,5 ,6 ]
Terao, Chikashi [7 ,8 ,9 ,10 ]
Sun, Celi [1 ]
Zhou, Xu-jie [11 ,12 ]
Raj, Prithvi [13 ]
Kochi, Yuta [14 ]
Suzuki, Akari [14 ]
Akizuki, Shuji [15 ]
Nakabo, Shuichiro [15 ]
Bang, So-Young [16 ]
Lee, Hye-Soon [16 ]
Kang, Young Mo [17 ]
Suh, Chang-Hee [18 ]
Chung, Won Tae [19 ]
Park, Yong-Beom [20 ]
Choe, Jung-Yoon [21 ]
Shim, Seung-Cheol [22 ]
Lee, Shin-Seok [23 ]
Zuo, Xiaoxia [24 ]
Yamamoto, Kazuhiko [14 ]
Li, Quan-Zhen [25 ]
Shen, Nan [26 ,27 ,28 ,29 ,30 ,31 ]
Porter, Lauren L. [2 ]
Harley, John B. [30 ,31 ,32 ]
Chua, Kek Heng [33 ]
Zhang, Hong [11 ,12 ]
Wakeland, Edward K. [13 ]
Tsao, Betty P. [34 ]
Bae, Sang-Cheol [16 ]
Nath, Swapan K. [1 ]
机构
[1] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA
[2] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA USA
[3] Kyung Hee Univ, Dept Biol, Seoul, South Korea
[4] Osaka Univ, Dept Stat Genet, Grad Sch Med, Osaka, Japan
[5] RIKEN, Lab Stat Anal, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan
[6] Osaka Univ, Immunol Frontier Res Ctr WPI IFReC, Lab Stat Immunol, Suita, Osaka, Japan
[7] Kyoto Univ, Ctr Genom Med, Grad Sch Med, Kyoto, Japan
[8] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Kyoto, Japan
[9] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA
[10] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA
[11] Peking Univ, Inst Nephrol, Renal Div, Key Lab Renal Dis,Hosp 1,Minist Hlth China, Beijing, Peoples R China
[12] Peking Univ, Minist Educ, Key Lab Chron Kidney Dis Prevent & Treatment, Beijing, Peoples R China
[13] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA
[14] RIKEN, Lab Autoimmune Dis, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan
[15] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan
[16] Hanyang Univ Hosp Rheumat Dis, Dept Rheumatol, Seoul, South Korea
[17] Kyungpook Natl Univ Hosp, Sch Med, Daegu, South Korea
[18] Ajou Univ Hosp, Dept Rheumatol, Suwon, South Korea
[19] Dong A Univ Hosp, Dept Internal Med, Busan, South Korea
[20] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea
[21] Catholic Univ, Dept Rheumatol, Daegu Sch Med, Daegu, South Korea
[22] Chungnam Natl Univ Hosp, Daejeon Rheumatoid & Degenerat Arthrit Ctr, Daejeon, South Korea
[23] Chonnam Natl Univ Med Sch & Hosp, Dept Rheumatol, Daejeon, South Korea
[24] Cent S Univ, Xiangya Hosp, Dept Rheumatol & Immunol, Changsha, Hunan, Peoples R China
[25] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol & Internal Med, Dallas, TX 75390 USA
[26] Shanghai Jiao Tong Univ, Renji Hosp, Dept Rheumatol, Sch Med, Shanghai, Peoples R China
[27] Shanghai Jiao Tong Univ, Shanghai Inst Rheumatol, Renji Hosp, Sch Med, Shanghai, Peoples R China
[28] Chinese Acad Sci, Inst Hlth Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China
[29] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
[30] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA
[31] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[32] US Dept Vet Affairs Med Ctr, Cincinnati, OH USA
[33] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia
[34] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA
来源
PLOS GENETICS | 2019年 / 15卷 / 04期
基金
新加坡国家研究基金会;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; PEPTIDE-BINDING POCKET; RHEUMATOID-ARTHRITIS; GENETIC ASSOCIATION; REVISED CRITERIA; SELF-PEPTIDES; DPB1; ALLELES; MHC REGION; LOCI;
D O I
10.1371/journal.pgen.1008092
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Human leukocyte antigen (HLA) is a key genetic factor conferring risk of systemic lupus erythematosus (SLE), but precise independent localization of HLA effects is extremely challenging. As a result, the contribution of specific HLA alleles and amino-acid residues to the overall risk of SLE and to risk of specific autoantibodies are far from completely understood. Here, we dissected (a) overall SLE association signals across HLA, (b) HLA-peptide interaction, and (c) residue-autoantibody association. Classical alleles, SNPs, and amino-acid residues of eight HLA genes were imputed across 4,915 SLE cases and 13,513 controls from Eastern Asia. We performed association followed by conditional analysis across HLA, assessing both overall SLE risk and risk of autoantibody production. DR15 alleles HLA-DRB1*15:01 (P = 1.4x10(-27), odds ratio (OR) = 1.57) and HLA-DQB1*06:02 (P = 7.4x10(-23), OR = 1.55) formed the most significant haplotype (OR = 2.33). Conditioned protein-residue signals were stronger than allele signals and mapped predominantly to HLA-DRB1 residue 13 (P = 2.2x10(-75)) and its proxy position 11 (P = 1.1x10(-67)), followed by HLA-DRB1-37 (P = 4.5x10(-24)). After conditioning on HLA-DRB1, novel associations at HLA-A-70 (P = 1.4x10(-8)), HLA-DPB1-35 (P = 9.0x10(-16)), HLA-DQB1-37 (P = 2.7x10(-14)), and HLA-B-9 (P = 6.5x10(-15)) emerged. Together, these seven residues increased the proportion of explained heritability due to HLA to 2.6%. Risk residues for both overall disease and hallmark autoantibodies (i.e., nRNP: DRB1-11, P = 2.0x10(-14); DRB1-13, P = 2.9x10(-13); DRB1-30, P = 3.9x10(-14)) localized to the peptide-binding groove of HLA-DRB1. Enrichment for specific amino-acid characteristics in the peptide-binding groove correlated with overall SLE risk and with autoantibody presence. Risk residues were in primarily negatively charged side-chains, in contrast with rheumatoid arthritis. We identified novel SLE signals in HLA Class I loci (HLA-A, HLA-B), and localized primary Class II signals to five residues in HLA-DRB1, HLA-DPB1, and HLA-DQB1. These findings provide insights about the mechanisms by which the risk residues interact with each other to produce autoantibodies and are involved in SLE pathophysiology. Author summary The Human leukocyte antigen (HLA) region is a key genetic factor conferring risk of systemic lupus erythematosus (SLE). In spite of multiple SLE association signals identified in the HLA region, only amino-acid residues within HLA-DRB1 have been specifically described previously. In this study, we performed an imputation-based analysis on individuals with East Asian ancestry, and characterized SLE risk within the HLA region for all involved independent genes (HLA-DRB1, HLA-DPB1, HLA-DQB1, HLA-A, and HLA-B). Furthermore, we identified a characteristic SLE risk residue signature as well as a pattern of specific nRNP and Ro/La autoantibody residues located in the peptide-binding grooves, suggesting their key involvement in autoantibody production.
引用
收藏
页数:25
相关论文
共 7 条
  • [1] SOLUBLE HLA-DR MOLECULES IN PATIENTS WITH HLA CLASS-II VERSUS CLASS-I ASSOCIATED DISORDERS
    WEYAND, CM
    JENDRO, M
    GORONZY, JJ
    AUTOIMMUNITY, 1991, 8 (04) : 281 - 287
  • [2] Amino acid signatures in the HLA class II peptide-binding region associated with protection/susceptibility to the severe West Nile Virus disease
    Sarri, Constantina A.
    Papadopoulos, Georgios E.
    Papa, Anna
    Tsakris, Athanasios
    Pervanidou, Danai
    Baka, Agoritsa
    Politis, Constantina
    Billinis, Charalambos
    Hadjichristodoulou, Christos
    Mamuris, Zissis
    PLOS ONE, 2018, 13 (10):
  • [3] Fine-mapping of HLA class I and class II genes identified two independent novel variants associated with nasopharyngeal carcinoma susceptibility
    Wang, Tong-Min
    Zhou, Ting
    He, Yong-Qiao
    Xue, Wen-Qiong
    Zhang, Jiang-Bo
    Zheng, Xiao-Hui
    Li, Xi-Zhao
    Zham, Shao-Dan
    Zeng, Yi-Xin
    Jia, Wei-Hua
    CANCER MEDICINE, 2018, 7 (12): : 6308 - 6316
  • [4] Effect of HLA Class I and Class II Alleles on Progression From Autoantibody Positivity to Overt Type 1 Diabetes in Children With Risk-Associated Class II Genotypes
    Lipponen, Kati
    Gombos, Zsofia
    Kiviniemi, Minna
    Siljander, Heli
    Lempainen, Johanna
    Hermann, Robert
    Veijola, Riitta
    Simell, Olli
    Knip, Mikael
    Ilonen, Jorma
    DIABETES, 2010, 59 (12) : 3253 - 3256
  • [5] HLA Class I and II Blocks Are Associated to Susceptibility, Clinical Subtypes and Autoantibodies in Mexican Systemic Sclerosis (SSc) Patients
    Rodriguez-Reyna, Tatiana S.
    Mercado-Velazquez, Pamela
    Yu, Neng
    Alosco, Sharon
    Ohashi, Marina
    Lebedeva, Tatiana
    Cruz-Lagunas, Alfredo
    Nunez-Alvarez, Carlos
    Cabiedes-Contreras, Javier
    Vargas-Alarcon, Gilberto
    Granados, Julio
    Zuniga, Joaquin
    Yunis, Edmond
    PLOS ONE, 2015, 10 (05):
  • [6] Susceptibility and Severity of COVID-19 Are Both Associated With Lower Overall Viral-Peptide Binding Repertoire of HLA Class I Molecules, Especially in Younger People
    Basir, Hamid Reza Ghasemi
    Majzoobi, Mohammad Mahdi
    Ebrahimi, Samaneh
    Noroozbeygi, Mina
    Hashemi, Seyed Hamid
    Keramat, Fariba
    Mamani, Mojgan
    Eini, Peyman
    Alizadeh, Saeed
    Solgi, Ghasem
    Di, Da
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] KIR specificity and avidity of standard and unusual C1, C2, Bw4, Bw6 and A3/11 amino acid motifs at entire HLA:KIR interface between NK and target cells, the functional and evolutionary classification of HLA class I molecules
    Gwozdowicz, Slawomir
    Nestorowicz, Klaudia
    Graczyk-Pol, Elzbieta
    Szlendak, Urszula
    Rogatko-Koros, Marta
    Mika-Witkowska, Renata
    Pawliczak, Daria
    Zubala, Marta
    Malinowska, Agnieszka
    Witkowska, Agnieszka
    Nowak, Jacek
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2019, 46 (04) : 217 - 231